Telomerase as a therapeutic target in cancer

Ginelle C. Gellert, Shalmica R. Jackson, Z. Gunnur Dikmen, Woodring E. Wright, Jerry W. Shay

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations


Advances in chromosome dynamics have increased our understanding of the significant role of telomeres and telomerase in cancer. Telomerase is expressed in almost all cancer cells but is inactive in most normal somatic cells. Therefore, telomerase is an important target for the design of therapeutic agents that might have minimal side effects. Herein, we evaluate current approaches to telomerase-targeted therapy, discuss the benefits and disadvantages, and speculate on the future direction of telomerase inhibitors as cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)159-164
Number of pages6
JournalDrug Discovery Today: Disease Mechanisms
Issue number2
StatePublished - 2005

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Telomerase as a therapeutic target in cancer'. Together they form a unique fingerprint.

Cite this